Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Berek

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 21, 2024
Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classificationDavid Mutch, David Gaffney, Xavier Matias-Guiu, et al.
Gynecologic Oncology|May 3, 2005
Lower urinary tract reconstruction with ileum in the treatment of gynecologic malignanciesJohn C Elkas, Jonathan S Berek, Ronald Leuchter, et al.
Clinical Obstetrics and Gynecology|May 22, 2007
Ovarian conservation at the time of hysterectomy for benign diseaseWilliam H Parker, Michael S Broder, Zhimei Liu, et al.
Menopause (New York, N.Y.)|May 4, 2007
Elective oophorectomy for benign gynecological disordersDonna Shoupe, William H Parker, Michael S Broder, et al.
Current Opinion in Obstetrics & Gynecology|July 13, 2007
Elective oophorectomy in the gynecological patient: when is it desirable?William H Parker, Donna Shoupe, Michael S Broder, et al.
Obstetrics and Gynecology|August 2, 2005
Ovarian conservation at the time of hysterectomy for benign diseaseWilliam H Parker, Michael S Broder, Zhimei Liu, et al.
Journal of Minimally Invasive Gynecology|April 22, 2018
Regarding "Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy with Morcellation"William H Parker, Jonathan S Berek, Elizabeth A Pritts, et al.
Psycho-Oncology|August 2, 2023
Changing cancer mindsets: A randomized controlled feasibility and efficacy trialSean R Zion, Lidia Schapira, Jonathan S Berek, et al.
Gynecologic Oncology|June 25, 2003
Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group studyPaula M Fracasso, John A Blessing, Judith Wolf, et al.
Journal of Minimally Invasive Gynecology|August 23, 2017
Regarding "Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy with Morcellation"William H Parker, Jonathan S Berek, Elizabeth A Pritts, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 21, 2024
Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classificationDavid Mutch, David Gaffney, Xavier Matias-Guiu, et al.
Gynecologic Oncology|May 3, 2005
Lower urinary tract reconstruction with ileum in the treatment of gynecologic malignanciesJohn C Elkas, Jonathan S Berek, Ronald Leuchter, et al.
Clinical Obstetrics and Gynecology|May 22, 2007
Ovarian conservation at the time of hysterectomy for benign diseaseWilliam H Parker, Michael S Broder, Zhimei Liu, et al.
Menopause (New York, N.Y.)|May 4, 2007
Elective oophorectomy for benign gynecological disordersDonna Shoupe, William H Parker, Michael S Broder, et al.
Current Opinion in Obstetrics & Gynecology|July 13, 2007
Elective oophorectomy in the gynecological patient: when is it desirable?William H Parker, Donna Shoupe, Michael S Broder, et al.
Obstetrics and Gynecology|August 2, 2005
Ovarian conservation at the time of hysterectomy for benign diseaseWilliam H Parker, Michael S Broder, Zhimei Liu, et al.
Journal of Minimally Invasive Gynecology|April 22, 2018
Regarding "Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy with Morcellation"William H Parker, Jonathan S Berek, Elizabeth A Pritts, et al.
Psycho-Oncology|August 2, 2023
Changing cancer mindsets: A randomized controlled feasibility and efficacy trialSean R Zion, Lidia Schapira, Jonathan S Berek, et al.
Gynecologic Oncology|June 25, 2003
Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group studyPaula M Fracasso, John A Blessing, Judith Wolf, et al.
Journal of Minimally Invasive Gynecology|August 23, 2017
Regarding "Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy with Morcellation"William H Parker, Jonathan S Berek, Elizabeth A Pritts, et al.
Pageof 14